It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Despite the availability of hepatitis B virus (HBV) and hepatitis C virus (HCV) testing in primary care, testing rates in China remain low. Social media is an inexpensive means of disseminating information and could facilitate hepatitis testing promotion. We evaluated the capacity of digitally crowdsourced materials to promote HBV/HCV testing uptake via a randomized controlled trial (identifier: ChiCTR1900025771), which enrolled 750 Chinese primary care patients. We randomized patients (1:1) to receive crowdsourced HBV/HCV promotion materials through social media or facility-based care without promotional materials for four weeks. Exposure to all intervention materials was associated with increased odds of HBV (aOR = 1.79, 95% CI: 1.09–3.00) and HCV (aOR = 1.95, 95% CI: 1.29–2.99) testing compared to facility-based care. There was a significant reduction in hepatitis stigma among intervention group participants (HBV slope: −0.15, p < 0.05; and HCV slope: −0.13, p < 0.05). Digitally crowdsourced promotion messages could enhance hepatitis testing uptake and should be considered in hepatitis reduction strategies.
Trial registration: Chinese Clinical Trial Registry (ChiCTR1900025771) on September 9, 2019. Available from: http://www.chictr.org.cn/showproj.aspx?proj=42788
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 The University of Hong Kong-Shenzhen Hospital, Department of Family Medicine & Primary Care, Shenzhen, China (GRID:grid.440671.0) (ISNI:0000 0004 5373 5131); The University of Hong Kong, Department of Family Medicine & Primary Care, Li Ka Shing Faculty of Medicine, Pok Fu Lam, Hong Kong (GRID:grid.194645.b) (ISNI:0000000121742757)
2 2nd Floor of Lao Gan Building, Yuexiu District, The University of North Carolina Project-China, Global Health Center Office, Guangzhou, China (GRID:grid.194645.b); Social Entrepreneurship to Spur Health (SESH), Guangzhou, China (GRID:grid.194645.b)
3 Social Entrepreneurship to Spur Health (SESH), Guangzhou, China (GRID:grid.194645.b)
4 The University of Hong Kong-Shenzhen Hospital, Department of Family Medicine & Primary Care, Shenzhen, China (GRID:grid.440671.0) (ISNI:0000 0004 5373 5131)
5 World Health Organization Western Pacific Regional Office, Manila, The Philippines (GRID:grid.440671.0)
6 2nd Floor of Lao Gan Building, Yuexiu District, The University of North Carolina Project-China, Global Health Center Office, Guangzhou, China (GRID:grid.440671.0); University of North Carolina, Institute of Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720); Faculty of Infectious and Tropical Diseases, LSHTM, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
7 2nd Floor of Lao Gan Building, Yuexiu District, The University of North Carolina Project-China, Global Health Center Office, Guangzhou, China (GRID:grid.8991.9); University of North Carolina, Institute of Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720); Guangdong Second Provincial General Hospital, Guangzhou, China (GRID:grid.413405.7) (ISNI:0000 0004 1808 0686)
8 Social Entrepreneurship to Spur Health (SESH), Guangzhou, China (GRID:grid.413405.7)
9 The University of Hong Kong-Shenzhen Hospital, Department of Medicine, Shenzhen, China (GRID:grid.440671.0) (ISNI:0000 0004 5373 5131); The University of Hong Kong, Department of Medicine and State Key Laboratory of Liver Research, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)